BIO-PATH HOLDINGS INC (BPTH) Jumps 10.08% on December 23

Equities Staff |

BIO-PATH HOLDINGS INC (BPTH) was among the biggest gainers on the Russell 2000 for Wednesday December 23 as the stock popped 10.08% to $1.31, representing a gain of $0.12 per share. Some 112,452 shares traded hands on 373 trades, compared with an average daily volume of 77,601 shares out of a total float of 89.76 million. The stock opened at $1.20 and traded with an intraday range of $1.33 to $1.16.

After today's gains, BIO-PATH HOLDINGS INC reached a market cap of $117.59 million. BIO-PATH HOLDINGS INC has had a trading range between $2.84 and $0.99 over the last year, and it had a 50-day SMA of $1.52 and a 200-day SMA of $1.36.

Bio-Path Holdings Inc is a development stage company. The Company with its lead cancer drug candidate, Liposomal Grb-2, is currently in clinical trials.

BIO-PATH HOLDINGS INC is based out of Bellaire, TX and has some 8 employees. Its CEO is Peter H. Nielsen.

For a complete fundamental analysis analysis of BIO-PATH HOLDINGS INC, check out’s Stock Valuation Analysis report for BPTH. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Breathtec BioMedical Inc.

Breathtec Biomedical Inc is a medical diagnostics company. It is engaged in developing & commercializing breath analysis devices for the early detection of infections & life threatening diseases including cancers,…

Private Markets


Snapchat is the fastest way to share a moment with friends. The mobile app, allows users to not only share photos with friends but also control how long they can…


Wealthfront is an automated investment service that serves as an alternative to traditional financial advisory services. The company manages a diversified, continually rebalanced portfolio of index funds on their clients’…